Hypoxia in tumors occurs when new blood vessels can not keep up with tumor growth and leads to the elevation of hypoxia-inducible factor-1α (HIF1α), which plays a vital role in NSCLC cells epithelial-to-mesenchymal transition (EMT) [4, 5]. This evidence concerns the gene HIF1A and non-small cell lung carcinoma.